VOV.VN - Vietnam will continue to produce its own coronavirus vaccines, facilitate clinical trials, and prepare vaccine production and funding plans providing the vaccines are effective.
As many as 554 volunteers joining the second-stage human trials of home-grown Nano Covax COVID-19 vaccine got the second shots over the past 14 days.
VOV.VN - Deputy Prime Minister Vu Duc Dam was given a second shot of the locally-produced Nano Covax novel coronavirus (COVID-19) vaccine as part of the second stage of human trials on March 26.
VOV.VN - Up to 26 volunteers received their second shots of the Nano Covax novel coronavirus (COVID-19) vaccine on March 25 at the Vietnam Military Medical University in Hanoi as part of the second-stage of human trials to test the domestically-produced vaccine.
VOV.VN - Scientists are speeding up the clinical trials of locally-produced coronavirus vaccines, and the first of its kind is likely to be rolled out by the end of the third quarter of this year.
VOV.VN - The Ministry of Health confirmed no new locally-transmitted COVID-19 cases on the morning of March 1, keeping the national tally at 2,448, while the total recoveries hit 1,876 in total after a further 32 coronavirus patients were declared free from the virus one day earlier.
VOV.VN - Covivac, a COVID-19 vaccine developed by the Institute of Vaccines and Medical Biology (Ivac), will be tested in healthy volunteers in Vietnam on March 3, Ivac has announced.
VOV.VN - Nano Covax, Vietnam’s first locally-produced COVID-19 vaccine, has elicited a host of antibodies that help to protect those injected against the B.1.1.7 variant of the SARS-CoV-2 virus which originates from the UK, according to a leading Vietnamese scientist.
VOV.VN - As many as 35 volunteers participated in the second phase of human trials for the locally-produced Nano Covax vaccine against the novel coronavirus (COVID-19) on February 26 at the Military Medical Academy in Hanoi.
VOV.VN - The second phase of human trials for the locally-produced Nano Covax vaccine against COVID-19 were launched on the morning of February 26, following the completion of the first phase to prove the vaccine’s safety.